Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Thynk Capital, LLC.
company
About
Historical Investment Performance in Top 1% of Venture Funds. Primary focus on Longevity and defeating Diseases of Aging.
- 1 - 10
Highlights
Details
- Industries
- Biotechnology,Health Care
- Founded date
- Mar 4, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Thynk Capital possess a historical investment performance in the top 1% of venture capital. Focused on investments in early stage pharma and biotech companies focused on extending HealthSpan and major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Cardiovascular, Diabetes, Frailty, and Rare Disease which affect over 25% of the population and growing at 10%/year.
Investments
Number of Investments
Number of Lead Investments
1
0
Thynk Capital, LLC. has made 1 investments. Their most recent investment was on
Nov 16, 2017, when X4 Pharmaceuticals raised 0.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 16, 2017
X4 Pharmaceuticals
|
Series A | — | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
